This is my fourth day, and I can assure you 100% that it hurts much less. I haven't dared to train legs yet, but I already notice that walking is much better.
I still can't believe it in just four days; I haven't done anything else.
Wanted to share my upcoming protocol since I've been reading this sub for a while and figured I'd contribute. Quick background: ACL reconstruction with partial medial meniscectomy a bit over a year ago, left knee. Recovery went mostly well but I've been dealing with persistent medial knee pain, more on the tibial side just below the joint line — feels more periarticular than intra-articular, classic pes anserine territory or possibly some subchondral involvement from the meniscectomy. Just had an MRI done, waiting on the radiologist's report to confirm what's going on, but I want to have my protocol ready to start once I have a clearer picture.
I went with BPC-157 and TB-4 (the native peptide, not TB-500 — wanted the real molecule rather than the synthetic fragment). Both sourced from a supplier with third-party HPLC, which I think matters more than people give it credit for. Half the conflicting experiences you read about in this space are probably just product quality variance.
My dosing plan is 500 mcg twice daily of each, so 1 mg total per day of BPC-157 and 1 mg total per day of TB-4. I know this is on the higher end of what people typically run, especially for TB-4 since most protocols you see are weekly loading doses in the 2-5 mg range. My reasoning for splitting it into twice daily is the short half-life of BPC subcutaneously — I'd rather keep more sustained exposure at the site than spike and crash with a single daily injection. For a chronic tendinopathy that's been sitting there for over a year, I figure sustained signaling is what I want, not pulses.
Administration plan is subQ as close to the site as I can get it, alternating injection points along the medial aspect of the knee around the pes anserinus insertion, basically a few finger-widths below the joint line on the anteromedial tibia. For TB-4 I might do some shots locally and some in the abdomen since it's more of a systemic player anyway — the literature on it suggests it travels and acts more broadly than BPC does. BPC I'll keep strictly local because the whole point of that one for tendons seems to be the local angiogenic and fibroblast effect.
Reconstitution: 5 mg vial with 2.5 ml bacteriostatic water gives me 2 mg/ml, which works out to 25 units on an insulin syringe per 500 mcg dose. Easy math, clean dosing. Storing reconstituted vials in the fridge and planning to use each within 3-4 weeks of reconstitution to stay on the safe side.
Cycle length I'm planning at 6 weeks minimum, possibly 8 depending on how I'm responding. Tendinous and cartilaginous tissue turns over slowly so I don't expect to feel much in the first two weeks. After the active cycle I'll take 4-6 weeks off completely and see if the clinical improvement holds — if it does, that suggests actual structural progress; if symptoms come back, then the peptides were just modulating inflammation without addressing the underlying mechanical cause, which would tell me I need to look harder at biomechanics and load management instead of throwing more compounds at it.
Couple of things I'm tracking honestly because I want to know what's working and what isn't. First, I'm running this alongside an existing TRT protocol and a GLP-1 (retatrutide), so I won't be able to perfectly attribute effects, but I'm not adding or changing anything else during the cycle so at least the peptides are the only new variable. Second, I had a recent episode of elevated resting heart rate and a transient visual aura that's still being worked up, so I'm going to be paying close attention to any cardiovascular signals during the cycle — TB-4 in particular has theoretical systemic angiogenic effects and I want to be honest with myself if I notice anything off rather than push through.
The rehab side is non-negotiable for me regardless of what the peptides do. Eccentric hamstring work, progressive loading on the knee, and addressing the quad deficit on the operated side that's almost certainly still there a year out and probably contributing to the medial overload. No peptide is going to fix bad biomechanics or a weak quad, and I think that's where a lot of people on this stuff get disappointed — they expect the compounds to do the work that loading should be doing.
I'll report back at the 3-week mark, end of cycle, and again after the washout. Happy to answer questions on sourcing